Funding and clinical trial-based barriers must be addressed to ensure success on the path to developing a DMT for Parkinson’s.

Quarterly Adjusted EBITDA -- $4.9 million, a $6.3 million improvement from negative $1.4 million in the prior year, with a ...

Learn what makes a psychiatric note compliant and clinically protective, including structured documentation that supports care decisions and clear records. The post What Makes a Psychiatric Note Clear ...

My initial comments will briefly highlight our fourth quarter and full-year 2025 results, along with the steps we are taking ...

Good morning, everyone, and welcome to the Abeona Therapeutics Full Year 2025 Results Conference Call. [Operator Instructions] Please note this conference is being recor ...

Q2 2026 Earnings Call March 17, 2026 7:00 AM EDTCompany ParticipantsChristopher Hand - Executive ChairmanThomas Hayes ...

The 2026 Annual Threat Assessment warns of escalating global threats: a five-fold rise in missiles targeting the US, Iran seeking revenge, North Korea’s expanding arsenal, and China’s race for AI ...

Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.

The introduction of vision-enabled artificial intelligence (AI) to medical scribes—the recording devices used by doctors to ...

Led by researchers at NDORMS as part of the Data Analysis and Real World Interrogation Network (DARWIN EU) initiative, a new ...

Latent Health is tapping into the $200 billion market for specialty drugs with AI agents that help doctors convince insurers ...

BACKGROUND: Premature atrial contractions (PACs) are independently associated with atrial fibrillation, stroke, and heart failure, yet no pharmacological therapy is approved for PAC suppression.